Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Losartan

The founder of the sartans: it was the first angiotensin II AT1 receptor blocker to reach the market, in the mid-1990s. It lowers blood pressure by blocking angiotensin II, a powerful vasoconstrictor. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?In 2006 a Johns Hopkins University study showed that losartan prevented aortic aneurysm in mice with Marfan syndrome, by damping down TGF-beta signalling.

LosartanGo to the active ingredient →
LosartanActive ingredientLosartanCat. No. P-L097-001CAS 114798-26-4
Losartan-d4Isotopically labelledLosartan-d4Cat. No. P-L097-025CAS 1030937-27-9

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.